Cargando…

Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review

BACKGROUND: Autosomal dominant familial cortical myoclonic tremor and epilepsy (FCMTE) is characterized by distal tremulous myoclonus, generalized seizures, and signs of cortical reflex myoclonus. FCMTE has been described in over 100 pedigrees worldwide, under several different names and acronyms. P...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Ende, Tom, Sharifi, Sarvi, van der Salm, Sandra M. A., van Rootselaar, Anne-Fleur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia University Libraries/Information Services 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801339/
https://www.ncbi.nlm.nih.gov/pubmed/29416935
http://dx.doi.org/10.7916/D85155WJ
_version_ 1783298334523392000
author van den Ende, Tom
Sharifi, Sarvi
van der Salm, Sandra M. A.
van Rootselaar, Anne-Fleur
author_facet van den Ende, Tom
Sharifi, Sarvi
van der Salm, Sandra M. A.
van Rootselaar, Anne-Fleur
author_sort van den Ende, Tom
collection PubMed
description BACKGROUND: Autosomal dominant familial cortical myoclonic tremor and epilepsy (FCMTE) is characterized by distal tremulous myoclonus, generalized seizures, and signs of cortical reflex myoclonus. FCMTE has been described in over 100 pedigrees worldwide, under several different names and acronyms. Pathological changes have been located in the cerebellum. This systematic review discusses the clinical spectrum, treatment, pathophysiology, and genetic findings. METHODS: We carried out a PubMed search, using a combination of the following search terms: cortical tremor, myoclonus, epilepsy, benign course, adult onset, familial, and autosomal dominant; this resulted in a total of 77 studies (761 patients; 126 pedigrees) fulfilling the inclusion and exclusion criteria. RESULTS: Phenotypic differences across pedigrees exist, possibly related to underlying genetic differences. A “benign” phenotype has been described in several Japanese families and pedigrees linked to 8q (FCMTE1). French patients (5p linkage; FCMTE3) exhibit more severe progression, and in Japanese/Chinese pedigrees (with unknown linkage) anticipation has been suggested. Preferred treatment is with valproate (mind teratogenicity), levetiracetam, and/or clonazepam. Several genes have been identified, which differ in potential pathogenicity. DISCUSSION: Based on the core features (above), the syndrome can be considered a distinct clinical entity. Clinical features may also include proximal myoclonus and mild progression with aging. Valproate or levetiracetam, with or without clonazepam, reduces symptoms. FCMTE is a heterogeneous disorder, and likely to include a variety of different conditions with mutations of different genes. Distinct phenotypic traits might reflect different genetic mutations. Genes involved in Purkinje cell outgrowth or those encoding for ion channels or neurotransmitters seem good candidate genes.
format Online
Article
Text
id pubmed-5801339
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Columbia University Libraries/Information Services
record_format MEDLINE/PubMed
spelling pubmed-58013392018-02-07 Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review van den Ende, Tom Sharifi, Sarvi van der Salm, Sandra M. A. van Rootselaar, Anne-Fleur Tremor Other Hyperkinet Mov (N Y) Reviews BACKGROUND: Autosomal dominant familial cortical myoclonic tremor and epilepsy (FCMTE) is characterized by distal tremulous myoclonus, generalized seizures, and signs of cortical reflex myoclonus. FCMTE has been described in over 100 pedigrees worldwide, under several different names and acronyms. Pathological changes have been located in the cerebellum. This systematic review discusses the clinical spectrum, treatment, pathophysiology, and genetic findings. METHODS: We carried out a PubMed search, using a combination of the following search terms: cortical tremor, myoclonus, epilepsy, benign course, adult onset, familial, and autosomal dominant; this resulted in a total of 77 studies (761 patients; 126 pedigrees) fulfilling the inclusion and exclusion criteria. RESULTS: Phenotypic differences across pedigrees exist, possibly related to underlying genetic differences. A “benign” phenotype has been described in several Japanese families and pedigrees linked to 8q (FCMTE1). French patients (5p linkage; FCMTE3) exhibit more severe progression, and in Japanese/Chinese pedigrees (with unknown linkage) anticipation has been suggested. Preferred treatment is with valproate (mind teratogenicity), levetiracetam, and/or clonazepam. Several genes have been identified, which differ in potential pathogenicity. DISCUSSION: Based on the core features (above), the syndrome can be considered a distinct clinical entity. Clinical features may also include proximal myoclonus and mild progression with aging. Valproate or levetiracetam, with or without clonazepam, reduces symptoms. FCMTE is a heterogeneous disorder, and likely to include a variety of different conditions with mutations of different genes. Distinct phenotypic traits might reflect different genetic mutations. Genes involved in Purkinje cell outgrowth or those encoding for ion channels or neurotransmitters seem good candidate genes. Columbia University Libraries/Information Services 2018-01-23 /pmc/articles/PMC5801339/ /pubmed/29416935 http://dx.doi.org/10.7916/D85155WJ Text en © 2018 van den Ende et al. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution–Noncommerical–No Derivatives License, which permits the user to copy, distribute, and transmit the work provided that the original author and source are credited; that no commercial use is made of the work; and that the work is not altered or transformed.
spellingShingle Reviews
van den Ende, Tom
Sharifi, Sarvi
van der Salm, Sandra M. A.
van Rootselaar, Anne-Fleur
Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review
title Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review
title_full Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review
title_fullStr Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review
title_full_unstemmed Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review
title_short Familial Cortical Myoclonic Tremor and Epilepsy, an Enigmatic Disorder: From Phenotypes to Pathophysiology and Genetics. A Systematic Review
title_sort familial cortical myoclonic tremor and epilepsy, an enigmatic disorder: from phenotypes to pathophysiology and genetics. a systematic review
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801339/
https://www.ncbi.nlm.nih.gov/pubmed/29416935
http://dx.doi.org/10.7916/D85155WJ
work_keys_str_mv AT vandenendetom familialcorticalmyoclonictremorandepilepsyanenigmaticdisorderfromphenotypestopathophysiologyandgeneticsasystematicreview
AT sharifisarvi familialcorticalmyoclonictremorandepilepsyanenigmaticdisorderfromphenotypestopathophysiologyandgeneticsasystematicreview
AT vandersalmsandrama familialcorticalmyoclonictremorandepilepsyanenigmaticdisorderfromphenotypestopathophysiologyandgeneticsasystematicreview
AT vanrootselaarannefleur familialcorticalmyoclonictremorandepilepsyanenigmaticdisorderfromphenotypestopathophysiologyandgeneticsasystematicreview